Edith Heard Unanimously Selected as Next Director General of EMBL
NewsAt its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organization’s fifth Director General. Heard’s mandate is scheduled to begin 1 January 2019.
Read moreInnate Reaction of Hematopoietic Stem Cells to Severe Infections
NewsResearchers at the University of Zurich have shown for the first time that hematopoietic stem cells detect infectious agents themselves and begin to divide, without signals from growth factors.
Read moreCow Antibodies Yield Important Clues For Developing A Broadly Effective AIDS Vaccine
NewsThe unexpected animal model is providing clues for important questions at a moment when new energy has infused HIV vaccine research.
Read moreCRISPR Reveals New Targets for Promising Cancer Drugs
NewsNovel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.
Read more
